1 / 2

Bortezomib injection

Bortezomib is an anticancer regimen used to treat blood malignancies. Bortecine is the brand name for this medicine. Patients with mantle cell lymphoma and multiple myeloma are treated with it. bortezomib injection shows side effects like constipation and nausea. It is available on Magicine Pharma at a low price. Check the pricing and get a 30% discount.<br>

15032
Download Presentation

Bortezomib injection

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Bortezomib injection Overview Bortezomib is an anticancer regimen used to treat blood malignancies. Bortecine is the brand name for this medicine. Patients with mantle cell lymphoma and multiple myeloma are treated with it. bortezomib injection shows side effects like constipation and nausea. It is available on Magicine Pharma at a low price. Check the pricing and get a 30% discount.

  2. Usage Of Medicine Bortecine comprises Bortezomib, which is used in the treatment of Multiple Myeloma and Mantle Cell Lymphoma. This medication is given as an injection. It is advisable to not stop taking this medicine without consulting a medical practitioner. Also, your healthcare provider will decide the dose strength and duration of this medication according to your current medical condition and medical history. Make sure to disclose the details of medicines you already take (including supplements) for better guidance. Pharmacodynamics Bortezomib targets the ubiquitin-proteasome pathway which is an essential molecular pathway regulating intracellular concentrations of proteins and promoting protein degradation. The ubiquitin-proteasome pathway is dysregulated in pathological conditions, which leads to aberrant pathway signaling and the formation of malignant cells. The molecular formula of Bortezomib is C19H25BN4O4. Its molecular mass is 384.237 g/mol.

More Related